These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors. Freire MCLC; Noske GD; Bitencourt NV; Sanches PRS; Santos-Filho NA; Gawriljuk VO; de Souza EP; Nogueira VHR; de Godoy MO; Nakamura AM; Fernandes RS; Godoy AS; Juliano MA; Peres BM; Barbosa CG; Moraes CB; Freitas-Junior LHG; Cilli EM; Guido RVC; Oliva G Molecules; 2021 Aug; 26(16):. PubMed ID: 34443484 [TBL] [Abstract][Full Text] [Related]
13. Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses. Hu Y; Ma C; Szeto T; Hurst B; Tarbet B; Wang J ACS Infect Dis; 2021 Mar; 7(3):586-597. PubMed ID: 33645977 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M Ghosh A; Chakraborty M; Chandra A; Alam MP J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023 [TBL] [Abstract][Full Text] [Related]
15. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166 [TBL] [Abstract][Full Text] [Related]
16. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL Du R; Cooper L; Chen Z; Lee H; Rong L; Cui Q Antiviral Res; 2021 Jun; 190():105075. PubMed ID: 33872675 [TBL] [Abstract][Full Text] [Related]
17. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies. Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299 [TBL] [Abstract][Full Text] [Related]
18. Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M Bekono BD; Onguéné PA; Simoben CV; Owono LCO; Ntie-Kang F Eur Biophys J; 2024 Aug; 53(5-6):277-298. PubMed ID: 38907013 [TBL] [Abstract][Full Text] [Related]
19. Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2. Al-Karmalawy AA; Farid MM; Mostafa A; Ragheb AY; H Mahmoud S; Shehata M; Shama NMA; GabAllah M; Mostafa-Hedeab G; Marzouk MM Molecules; 2021 Oct; 26(21):. PubMed ID: 34770969 [TBL] [Abstract][Full Text] [Related]
20. Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study. ElNaggar MH; Abdelwahab GM; Kutkat O; GabAllah M; Ali MA; El-Metwally MEA; Sayed AM; Abdelmohsen UR; Khalil AT Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]